Events
> 50th Polio Vaccine Anniversary
Important
Leaders & Contacts
in Polio Immunization
|
Important leaders in polio immunization: |
|
Other
resources (history of polio): |
|
|
Important
leaders in polio immunization |
|
|
Jennifer
L. Howse, Ph.D.
President of the
March of Dimes. Since
1990, Dr. Howse has
led the March of
Dimes, the organization
that supported Dr.
Jonas Salk's development
of the polio vaccine
that bears his name,
as well as the Sabin
(oral) vaccine. Dr.
Howse has served
as an advisor to
the Director of the
U.S. Centers for
Disease Control and
Prevention, and the
HHS Secretary’s
National Commission
on Infant Mortality.
Anna
Eleanor Roosevelt
Ms. Roosevelt is
the granddaughter
of President Franklin
D. Roosevelt, who
founded the March
of Dimes in 1938
to fight polio. She
is Director of Community
and Education Relations
at Boeing World Headquarters
in Chicago. She serves
as National Chair
of the Salk Vaccine
50th Anniversary
and is a member and
Secretary of the
March of Dimes Board
of Trustees.
Anita
Perry
First Lady of Texas.
Mrs. Perry is a long-time
volunteer for the
March of Dimes and
serves as March of
Dimes National Chair
for Childhood Immunization.
Contact
for those listed
above at the March
of Dimes is: Michele
Kling, Senior Health
& Science Press
Officer, 914-997-4613,
mkling@marchofdimes.com
Top
|
|
Centers
for Disease Control
and Prevention |
|
Dr.
Steve Cochi
Dr. Cochi has worked
at CDC in the field
of immunization for
more that 21 years.
From 1993-2003, he
led CDC’s global
immunization activities,
directing a $150 million
annual program with
90 CDC staff to provide
technical and programmatic
support. Global immunization
activities in this
period included oversight
of key partnerships
in the global polio
eradication initiative.
Contact
for Dr. Cochi is: Curtis
Allen, Health Communications
Specialist, 404-639-8487,
CAllen@cdc.gov
Top |
|
Rotary
International |
|
Mr.
William T. Sergeant
He has chaired Rotary's
International PolioPlus
Committee since 1994.
Contact
for Mr. Sergeant is:
Carol Pandak; Manager,
Division of PolioPlus;
847-866-3304; pandakc@rotaryintl.org
or
Vivian Fiore, Senior
Media Relations Specialist,
PolioPlus, 847-866-3234,
fiorev@rotaryintl.org
Top |
|
Salk
Institute |
|
Rich Murphy, President
and CEO
Can speak to the overall
mission of the Institute,
its history and its
legacy.
Salk
faculty members
Several members have
expertise in virology
and infectious diseases,
and they could be used
as scientific consultants.
Contact
for those listed above
at the Salk Institute
is: Cathy Yarbrough,
Vice President, Communications,
858-453-4100 x1290
yarbrough@salk.edu
Top
|
|
University
of Michigan |
|
Media contact is: Colleen Newvine, University
of Michigan News Service, 734-647-4411 direct,
734-764-7260 main, 734-764-7084 fax, cnewvine@umich.edu
Contact
for general information is: Terri Weinstein
Mellow, Director of Communications, School
of Public Health, 734-764-8094 direct, 734-763-5455
fax, twm@umich.edu
Top |
|
University
of Pittsburgh |
|
Julius S. Youngner,
Sc.D.
Dr. Youngner is the
only survivor of Salk’s
core scientific team.
As senior scientist,
he was responsible
for significant discoveries
that helped move the
vaccine research forward.
In particular, he established
techniques for trypsinization,
which allowed the production
of poliovirus on a
large scale, and he
developed a process
to inactivate the virus’
capability to cause
infection without destroying
its effectiveness as
a vaccine. He also
devised a methodology
for safety testing
of vaccine batches,
including those used
in the first field
trial, and designed
a simple color test
to measure antibodies
against polio that
was used to determine
the efficacy of immunization
in human subjects.
Dr. Youngner currently
is Distinguished Service
Professor Emeritus
of Molecular Genetics
and Biochemistry at
the University of Pittsburgh
School of Medicine.
Charles
R. Rinaldo, Ph.D.
Dr. Rinaldo is professor
and chairman, Department
of Infectious Diseases
and Microbiology at
the University of Pittsburgh
Graduate School of
Public Health. He is
an authority on the
gamma globulin field
trials of 1951 –
1953 that were spearheaded
by William Hammon,
M.D., Dr. P.H., the
University of Pittsburgh’s
inaugural chairman
of the Department of
Epidemiology and Microbiology
at the School of Public
Health.
Contact
for Dr. Youngner and
Dr. Rinaldo is: Lisa
Rossi, Associate Director,
News Bureau, University
of Pittsburgh Medical
Center and University
of Pittsburgh Schools
of the Health Sciences,
412-647-3555, rossiL@upmc.edu
Top |
|
Other
Resources (History of
Polio) |
|
|
Whatever
Happened to Polio?
OPENS: April 12, 2005
CLOSES: April 2006
Remember
polio, the debilitating,
paralyzing illness
that could strike at
any moment? To commemorate
the 50th anniversary
of the announcement
of an effective polio
vaccine, the museum
will open "Whatever
Happened to Polio."
This multi-media exhibition
will present the story
of polio, primarily
from the perspective
of the patient; the
vaccine development
that ended polio in
the U.S.; and the story
of survivors and the
changes they have made
in American society.
Katherine
Ott, Ph.D., Curator
Has expertise in the
history of medicine,
polio, disability and
related topics.
Contact
for Dr. Ott is: Valeska
Hilbig, Deputy Director,
Office of Public Affairs
(202) 633-3129, hilbigv@si.edu
|
|
|
Top
.pdf
Files - To
view and print the .pdf files on this
site, you will need Adobe Acrobat Reader.
Use this link to obtain a free copy of
the Adobe
Acrobat Reader. We highly recommend
that you upgrade to version 5.0 if haven't
already.
|